Triamterene and Hydrochlorothiazide
- Product NDC
- 50090-7437
- 11-digit product format
- 500907437
- Labeler code
- 50090
- Product ID
- 50090-7437_59f02578-c37e-408c-86fd-9522d09af558
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA208358
- Marketing category
- ANDA
- Marketing start
- 2020-02-21
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25; 37.5 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| WS821Z52LQ | TRIAMTERENE | 396-01-0 | TRIAMTERENE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7437-0 | 50090743700 | 30 CAPSULE in 1 BOTTLE (50090-7437-0) | 30 capsule | 2024-11-06 | No | No | Historical |
| 50090-7437-1 | 50090743701 | 100 CAPSULE in 1 BOTTLE (50090-7437-1) | 100 capsule | 2024-11-06 | No | No | Historical |
| 50090-7437-4 | 50090743704 | 90 CAPSULE in 1 BOTTLE (50090-7437-4) | 90 capsule | 2024-11-06 | No | No | Historical |